Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia by Rock Matthew J, Prenen Jean, Funari Vincent A, Funari Tara L, Merriman Barry, Nelson Stanley F, Lachman Ralph S, Wilcox William R, Reyno Soraya, Quadrelli Roberto, Vaglio Alicia, Owsianik Grzegorz, Janssens Annelies, Voets Thomas, Ikegawa Shiro, Nagai Toshiro, Rimoin David L, Nilius Bernd, Cohn Daniel H in Nature genetics (2008). PubMed


The brachyolmias constitute a clinically and genetically heterogeneous group of skeletal dysplasias characterized by a short trunk, scoliosis and mild short stature. Here, we identify a locus for an autosomal dominant form of brachyolmia on chromosome 12q24.1-12q24.2. Among the genes in the genetic interval, we selected TRPV4, which encodes a calcium permeable cation channel of the transient receptor potential (TRP) vanilloid family, as a candidate gene because of its cartilage-selective gene expression pattern. In two families with the phenotype, we identified point mutations in TRPV4 that encoded R616Q and V620I substitutions, respectively. Patch clamp studies of transfected HEK cells showed that both mutations resulted in a dramatic gain of function characterized by increased constitutive activity and elevated channel activation by either mechano-stimulation or agonist stimulation by arachidonic acid or the TRPV4-specific agonist 4alpha-phorbol 12,13-didecanoate (4alphaPDD). This study thus defines a previously unknown mechanism, activation of a calcium-permeable TRP ion channel, in skeletal dysplasia pathogenesis.

[ hide abstract ]

Discussed In Paper


Dosing Information

No dosing information annotated.